MIRA INFORM REPORT

Report Date :

13.02.2012

IDENTIFICATION DETAILS

Name :	MEDVITA PHARMA LTD

Registered Office :	c/o Hughes & Associates Secretarial Ltd. Unit D, 13/F., Tak Lee Commercial Building, 113-117 Wanchai Road, Wanchai

Country :	Hong Kong

Date of Incorporation :	25.08.2011

Com. Reg. No.:	58951073

Legal Form :	private limited liability

Line of Business :	Importer, Exporter and Wholesaler of all kinds of pharmaceuticals, chemical raw materials, etc.

No. of Employees :	Not Available

RATING & COMMENTS

MIRA’s Rating :

RATING

STATUS

PROPOSED CREDIT LINE

New Business

Status :	New company
Payment Behaviour :	Unknown
Litigation :	Clear

NOTES :

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

ECGC Country Risk Classification List – September 30, 2011

Country Name

Previous Rating

(30.06.2011)

Current Rating

(30.09.2011)

Hong Kong

Risk Category	ECGC Classification
Insignificant	A1
Low	A2
Moderate	B1
High	B2
Very High	C1
Restricted	C2
Off-credit	D

Company name

MEDVITA PHARMA LTD

Company ADDRESS

c/o Hughes & Associates Secretarial Ltd.

Unit D, 13/F., Tak Lee Commercial Building, 113-117 Wanchai Road, Wanchai, Hong Kong.

PHONE: Not available

FAX: Not available

MANAGEMENT

Managing Director: Mr. Alan John Bell (Mobile: 9123 3475)

SUMMARY

Incorporated on : 25th August, 2011.

Organization : Private Limited Company.

Capital: Nominal : HK$10,000.00

Issued : HK$1,000.00

Business Category : Importer, Exporter and Wholesaler.

Employees : Nil.

Main Dealing Banker : The Hongkong & Shanghai Banking Corp. Ltd., Hong Kong.

Banking Relation : Too early to comment.

Company name

MEDVITA PHARMA LTD.

Company ADDRESS

Registered Head Office:-

c/o Hughes & Associates Secretarial Ltd.

Unit D, 13/F., Tak Lee Commercial Building, 113-117 Wanchai Road, Wanchai, Hong Kong.

Associated Company:-

Bellpharm Chemicals Ltd., Hong Kong. [Dormant]

BUSINESS REGISTRATION NUMBER

58951073

COMPANY FILE NUMBER

1660019

MANAGEMENT

Managing Director: Mr. Alan John Bell

CAPITAL

Nominal Share Capital: HK$10,000.00 (Divided into 10,000 shares of HK$1.00 each)

Issued Share Capital: HK$1,000.00

SHAREHOLDER

(As per registry dated 25-08-2011)

Name		No. of shares
Alan John BELL		1,000 ====

Name

No. of shares

Alan John BELL

1,000

====

DIRECTOR

(As per registry dated 25-08-2011)

Name (Nationality)	Address
Alan John BELL	Flat A, 40/F., Tower 12, Carmel Cove, Caribbean Coast, 1 Kin Tung Road, Tung Chung, Lantau Island, Hong Kong.

Name

(Nationality)

Address

Alan John BELL

Flat A, 40/F., Tower 12, Carmel Cove, Caribbean Coast, 1 Kin Tung Road, Tung Chung, Lantau Island, Hong Kong.

SECRETARY

(As per registry dated 25-08-2011)

Name	Address	Co. No.
Hughes & Associates Secretarial Ltd.	Unit D, 13/F., Tak Lee Commercial Building, 113-117 Wanchai Road, Wanchai, Hong Kong.	0669106

HISTORY

The subject was incorporated on 25th August, 2011 as a private limited liability company under the Hong Kong Companies Ordinance.

Apart from these, neither material change nor amendment has been ever traced and noted.

OPERATIONS

Activities : Importer, Exporter and Wholesaler.

Lines : All kinds of pharmaceuticals, chemical raw materials, etc.

Employees : Nil.

Commodities Imported : India, Europe, etc.

Markets : China, other Asian countries, etc.

Annual Turnover : Too early to obtain figure.

Terms/Sales : L/C, T/T, etc.

Terms/Buying : Prepayment, L/C, etc.

FINANCIAL INFORMATION

Nominal Share Capital : HK$10,000.00 (Divided into 10,000 shares of HK$1.00 each)

Issued Share Capital : HK$1,000.00

Profit or Loss : Too early to offer an opinion.

Condition : Business is under development.

Facilities : Making fairly active use of general banking facilities.

Payment : Met trade commitments as required.

Commercial Morality : Too early to comment.

Banker : The Hongkong & Shanghai Banking Corp. Ltd., Hong Kong.

Standing : Small.

GENERAL

Having issued 1,000 ordinary shares of HK$1.00 each, Medvita Pharma Ltd. is wholly owned by Mr. Alan John Bell. He is a Hong Kong ID Card holder and has got the right to reside in Hong Kong permanently. He is also the only director of the subject.

The subject does not have its own operating office. Its registered office is in a commercial service firm located at Unit D, 13/F., Tak Lee Commercial Building, 113-117 Wanchai Road, Wanchai, Hong Kong known as Hughes & Associates Secretarial Ltd. which is handling its correspondences and documents. This firm is also the corporate secretary of the subject.

The subject has no employees in Hong Kong.

The subject’s operating office seems to be in the residence of Bell which is located at Flat A, 40/F., Tower 12, Carmel Cove, Caribbean Coast, 1 Kin Tung Road, Tung Chung, Lantau Island, Hong Kong.

The subject has had an associated company Bellpharm Chemicals Ltd., a Hong Kong-registered firm, which has commenced dormancy since 28th December, 2011.

The subject is trading in pharmaceuticals, chemical raw materials, etc. Products are imported from India, Europe, etc. Prime markets are China, other Asian countries, etc. Business is still under development.

The subject is just a one-man company. History in Hong Kong is just over five months.

Since the subject does not have its own operating office and has no employees in Hong Kong, consider it good for business engagements on L/C basis.

FOREIGN EXCHANGE RATES

Currency	Unit	Indian Rupees
US Dollar	1	Rs.49.64
UK Pound	1	Rs.78.35
Euro	1	Rs.65.79

RATING EXPLANATIONS

RATING		STATUS	PROPOSED CREDIT LINE
>86	Aaa	Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums	Unlimited
71-85	Aa	Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums	Large
56-70	A	Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums	Fairly Large
41-55	Ba	Overall operation is considered normal. Capable to meet normal commitments.	Satisfactory
26-40	B	Capability to overcome financial difficulties seems comparatively below average.	Small
11-25	Ca	Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity	Limited with full security
<10	C	Absolute credit risk exists. Caution needed to be exercised	Credit not recommended
--	NB	New Business	--

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

Financial condition (40%) Ownership background (20%) Payment record (10%)

Credit history (10%) Market trend (10%) Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.